Lymphogranulomatosis: a comprehensive literature review
Main Article Content
Abstract
Lymphogranulomatosis, commonly known as Hodgkin lymphoma, is a malignant lymphoid disorder marked by the presence of Reed–Sternberg cells. The disease shows distinctive epidemiological features, a well‑defined pathogenesis, and characteristic clinical manifestations. This review presents a humanised, expanded and clinically relevant overview covering epidemiology, pathogenesis, symptomatology, diagnostic strategies, staging, laboratory and imaging findings, treatment options, complications, and emerging therapies.
Article Details
References
Connors JM. Hodgkin lymphoma: epidemiology and outcomes. Link: https://pubmed.ncbi.nlm.nih.gov/?term=Connors+JM+Hodgkin+lymphoma
Ansell SM. Hodgkin lymphoma: biology and treatment. Link: https://pubmed.ncbi.nlm.nih.gov/?term=Ansell+SM+Hodgkin+lymphoma
Hoppe RT. Modern management of early‑stage Hodgkin lymphoma. Link: https://pubmed.ncbi.nlm.nih.gov/?term=Hoppe+RT+Hodgkin+lymphoma
Younes A. Contemporary management of Hodgkin lymphoma. Link: https://pubmed.ncbi.nlm.nih.gov/?term=Younes+A+Hodgkin+lymphoma
Cheson BD. PET‑CT in staging and evaluation of lymphoma. Link: https://pubmed.ncbi.nlm.nih.gov/?term=Cheson+BD+lymphoma+PET-CT
Moskowitz CH. Advances in relapsed Hodgkin lymphoma therapy. Link: https://pubmed.ncbi.nlm.nih.gov/?term=Moskowitz+CH+Hodgkin+lymphoma
